APA (7th ed.) Citation

F, M., M, R., B, M., E, G., MT, B., H, L., . . . M, S. (2025). Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study. JCO global oncology, 11, e2500376. https://doi.org/10.1200/GO-25-00376

Chicago Style (17th ed.) Citation

F, Massari, et al. "Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study." JCO Global Oncology 11 (2025): e2500376. https://doi.org/10.1200/GO-25-00376.

MLA (9th ed.) Citation

F, Massari, et al. "Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study." JCO Global Oncology, vol. 11, 2025, p. e2500376, https://doi.org/10.1200/GO-25-00376.